STOCK TITAN

Kewaunee Scientific (KEQU) CFO awarded 5,428 RSUs vesting from 2027

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Gardner Donald T. III reported acquisition or exercise transactions in this Form 4 filing.

Kewaunee Scientific reported that Chief Financial Officer Donald T. Gardner III received a compensation-related grant of derivative securities. He was awarded 5,428 restricted stock units linked to the company’s common stock, with each unit representing the right to receive one share in the future.

The restricted stock units will vest in three equal annual installments beginning on June 30, 2027, conditioned on his continued employment with the company. Following this grant, his reported holding of these FY27 restricted stock units is 5,428 units.

Positive

  • None.

Negative

  • None.
Insider Gardner Donald T. III
Role Chief Financial Officer
Type Security Shares Price Value
Grant/Award Restricted Stock Units FY27 5,428 $0.00 --
Holdings After Transaction: Restricted Stock Units FY27 — 5,428 shares (Direct, null)
Footnotes (1)
  1. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units shall vest in three equal annual installments beginning June 30, 2027, subject to the reporting person's continued employment with the Company.
RSUs granted 5,428 units Restricted Stock Units FY27 granted to CFO
RSU underlying shares 5,428 shares Common stock issuable upon vesting
Post-grant RSU holdings 5,428 units Total FY27 restricted stock units after grant
Grant price $0.00 per unit Compensation grant with no cash paid by insider
Vesting start date June 30, 2027 First of three equal annual vesting dates
Vesting schedule length 3 annual installments RSUs vest over three years, subject to employment
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"represents a contingent right to receive one share of the Company's common stock"
vest financial
"The restricted stock units shall vest in three equal annual installments"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual installments financial
"shall vest in three equal annual installments beginning June 30, 2027"
continued employment financial
"subject to the reporting person's continued employment with the Company"
Continued employment means that an individual remains in their current job without interruption. For investors, it signals stability and ongoing work that can affect company performance and future prospects. Like a steady heartbeat for a business, sustained employment helps ensure consistent operations and financial health.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gardner Donald T. III

(Last)(First)(Middle)
2700 WEST FRONT STREET

(Street)
STATESVILLE NORTH CAROLINA 28677

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units FY27(1)06/24/2026A5,428 (2) (2)Common Stock5,428$05,428D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
2. The restricted stock units shall vest in three equal annual installments beginning June 30, 2027, subject to the reporting person's continued employment with the Company.
Remarks:
/s/ Donald T. Gardner III06/25/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did KEQU report for CFO Donald T. Gardner III?

Kewaunee Scientific reported that CFO Donald T. Gardner III received 5,428 restricted stock units as a compensation grant. These units are derivative securities tied to common stock and increase his potential future equity stake, subject to vesting conditions and continued employment.

How many restricted stock units were granted to KEQU’s CFO in this Form 4?

The CFO was granted 5,428 restricted stock units. Each restricted stock unit corresponds to one share of Kewaunee Scientific common stock, giving him a potential future claim on 5,428 shares once vesting and employment conditions are satisfied over time.

When do the new KEQU restricted stock units for the CFO vest?

The restricted stock units vest in three equal annual installments starting June 30, 2027. Vesting continues over three years and is conditioned on the CFO’s continued employment with Kewaunee Scientific, aligning the equity award with long-term service and retention incentives.

What does each KEQU restricted stock unit granted to the CFO represent?

Each restricted stock unit represents a contingent right to receive one share of Kewaunee Scientific common stock. The right becomes actual shares only as the units vest according to the schedule beginning June 30, 2027, assuming ongoing employment requirements are met.

Is the KEQU CFO’s Form 4 transaction a market purchase or sale of shares?

The transaction is an award, not a market trade. It reflects a grant of 5,428 restricted stock units at no cash price, recorded as a compensation-related acquisition rather than an open-market purchase or sale of Kewaunee Scientific common stock.